Showing results (331-340 of 419) with videos related to
Sort By:
Pageof 42
Science Translational Medicine|May 26, 2017
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancyKatherine S Yang, Hyungsoon Im, Seonki Hong, et al.Journal of Experimental & Clinical Cancer Research : CR|June 5, 2026
B7-H3 CAR T cells eradicate intrahepatic cholangiocarcinoma and induce durable responseShahrzad Arya, Marco Ventin, Giulia Cattaneo, et al.Nature Communications|December 5, 2014
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsTalib Hassan Ali, Simona Pisanti, Elena Ciaglia, et al.Cancer Immunology, Immunotherapy : CII|July 22, 2008
Chordoma and chondrosarcoma gene profile: implications for immunotherapyJoseph H Schwab, Patrick J Boland, Narasimhan P Agaram, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2007
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapyJean-Philippe Theurillat, Ursina Zürrer-Härdi, Zsuzsanna Varga, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-ResistanceSimone Stupia, Christina Heeke, Alicia Brüggemann, et al.Cancer Research|January 20, 2019
Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial TranscriptionSong Fan, Tian Tian, Weixiong Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancerPaul Sabbatini, Jakob Dupont, Carol Aghajanian, et al.Biology|February 25, 2022
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and RectumAlessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, et al.Translational Oncology|June 24, 2025
Epigenetic modifiers to enhance the efficacy of immune checkpoint inhibitors for the treatment of melanomaLuigi Liguori, Angelo Luciano, Valentina Pagliara, et al.Pageof 42